Dojolvi side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Dojolvi. Common side effects include diarrhoea among females, and abdominal discomfort among males.
The phase IV clinical study is created by eHealthMe based on 357 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
357 people who take Dojolvi and have side effects are studied.
What is Dojolvi?
Dojolvi has active ingredients of triheptanoin. Currently, eHealthMe is studying from 207 Dojolvi users.
Number of Dojolvi reports submitted per year:
Dojolvi side effects by time on the drug *:
Dojolvi side effects by gender *:
Dojolvi side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Dojolvi?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on triheptanoin (the active ingredients of Dojolvi) and Dojolvi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Dojolvi:
- Dojolvi (207 reports)
All Dojolvi side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D and Lybalvi drug interaction - 5 seconds ago
- Glycopyrrolate and Sinusitis - 6 seconds ago
- Glycopyrrolate and Sinusitis - Acute - 6 seconds ago
- Miochol and High Blood Pressure - 7 seconds ago
- Clopidogrel and Malabsorption - 11 seconds ago
- Fioricet and Mucinex D drug interaction - 12 seconds ago
- Urocit-K and Xolair drug interaction - 15 seconds ago
- Tradjenta and Stribild drug interaction - 19 seconds ago
- Purinethol and Hypoglycaemia Aggravated - 25 seconds ago
- Lupron and Nearsightedness - 28 seconds ago